Difficulty: Medium
Average Score: 68%
Practice
Which of the following benzodiazepines has the shortest duration of action?
Correct answer
A
Rationale
In pharmacological lifespan treatment, understanding the pharmacokinetics of benzodiazepines is crucial for safe and effective prescribing practices. The correct answer is A) Triazolam, which has the shortest duration of action among the listed options. Triazolam is a short-acting benzodiazepine commonly used for the treatment of insomnia due to its rapid onset and short half-life.
Clorazepate (B) and Chlordiazepoxide (D) are both long-acting benzodiazepines with active metabolites that contribute to their prolonged duration of action. Prazepam (C) is an intermediate-acting benzodiazepine, which has a longer duration of action compared to Triazolam but shorter than Clorazepate and Chlordiazepoxide.
Educationally, knowing the duration of action of benzodiazepines is essential for tailoring treatment to individual patient needs. Short-acting benzodiazepines like Triazolam are preferred for acute situations requiring rapid onset and short-term relief, while long-acting benzodiazepines are more suitable for chronic conditions requiring sustained symptom control. Understanding these distinctions helps healthcare providers optimize therapy and minimize the risk of adverse effects such as tolerance, dependence, and withdrawal.
Clorazepate (B) and Chlordiazepoxide (D) are both long-acting benzodiazepines with active metabolites that contribute to their prolonged duration of action. Prazepam (C) is an intermediate-acting benzodiazepine, which has a longer duration of action compared to Triazolam but shorter than Clorazepate and Chlordiazepoxide.
Educationally, knowing the duration of action of benzodiazepines is essential for tailoring treatment to individual patient needs. Short-acting benzodiazepines like Triazolam are preferred for acute situations requiring rapid onset and short-term relief, while long-acting benzodiazepines are more suitable for chronic conditions requiring sustained symptom control. Understanding these distinctions helps healthcare providers optimize therapy and minimize the risk of adverse effects such as tolerance, dependence, and withdrawal.